Marshall Wace, LLP Celcuity Inc. Transaction History
Marshall Wace, LLP
- $77.3 Billion
- Q3 2024
A detailed history of Marshall Wace, LLP transactions in Celcuity Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 11,877 shares of CELC stock, worth $147,987. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,877
Previous 152,291
92.2%
Holding current value
$147,987
Previous $2.49 Million
92.9%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding CELC
# of Institutions
107Shares Held
30.3MCall Options Held
30.8KPut Options Held
152K-
Bvf Inc San Francisco, CA3.47MShares$43.2 Million1.64% of portfolio
-
Perceptive Advisors LLC New York, NY2.36MShares$29.4 Million0.92% of portfolio
-
Baker Bros. Advisors LP New York, NY1.87MShares$23.4 Million0.3% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.63MShares$20.3 Million0.0% of portfolio
-
Eventide Asset Management, LLC Boston, MA1.54MShares$19.1 Million0.4% of portfolio
About Celcuity Inc.
- Ticker CELC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 14,941,300
- Market Cap $186M
- Description
- Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therap...